PhRMA

News

White House wins in first Medicare negotiation legal ruling

A judge in a federal court in Texas has thrown out a lawsuit brought by the pharma industry challenging legislation introduced by the Biden administration that allows Medi

News

Pharma incensed by EU's compulsory licensing proposal

Pharma industry bodies have slammed a proposal by the European Commission to set up a compulsory licensing (CL) framework for medicines in emergency situations, claiming t

News

PhRMA makes its move on Medicare price negotiation

Legal challenges to Medicare’s price negotiation initiative introduced in the Inflation Reduction Act (IRA) continue to emerge, with pharmaceutical trade organisation PhRM

Market Access

US Democrats' blockbuster budget bill could spell big change...

The Inflation Reduction Act of 2022, a sweeping measure that now looks likely to be passed through budget reconciliation by Senate Democrats in the US, contains measures intended to greatly

Digital

Top 5 takeaways from international hybrid and virtual meetin...

The move to online international meetings has left pharma companies with uncertainty around contact compliance.

Views & Analysis

Why the drug pricing debate is focused on insulin

The treatment has been around for over a century but insulin has still become the centre of the ongoing discussion over pricing of pharmaceutical products.

White House wins in first Medicare negotiation legal ruling

Pharma incensed by EU's compulsory licensing proposal

PhRMA makes its move on Medicare price negotiation

US Democrats' blockbuster budget bill could spell big change...

Top 5 takeaways from international hybrid and virtual meetin...

Why the drug pricing debate is focused on insulin

Allogeneic cell therapy isn’t dead, with Brian Culley

How to meet your physicians where they are online

PhRMA

Editor's Picks